Molecular Response Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Employees
-
15
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
2
Molecular Response General Information
Description
Provider of molecular diagnostic services dedicated to the identification and advancement of high-value therapeutics. The company's advanced human biologic platforms provide a clinically relevant molecular response and biomarker data that accelerate novel or improved therapeutic drug development processes and programs through intelligently designed, patient-derived tumour models, enabling pharmaceutical partners to realize efficiencies in drug development through the use of clinically proven molecular markers.
Contact Information
Website
www.molecularresponse.comCorporate Office
- 11011 Torreyana Road
- Suite 190
- San Diego, CA 92121
- United States
Corporate Office
- 11011 Torreyana Road
- Suite 190
- San Diego, CA 92121
- United States
Molecular Response Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Molecular Response Comparisons
Industry
Financing
Details
Molecular Response Competitors (21)
One of Molecular Response’s 21 competitors is MatTek, a Corporate Backed or Acquired company based in Ashland, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MatTek | Corporate Backed or Acquired | Ashland, MA | ||||
| iXCells Biotechnologies | Private Equity-Backed | San Diego, CA | ||||
| Maze Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Cell Biologics | Corporation | Chicago, IL | ||||
| BioIVT | Private Equity-Backed | Westbury, NY |
Molecular Response Patents
Molecular Response Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160274085-A1 | 3d cell culture and ex vivo drug testing methods | Inactive | 15-Nov-2013 | ||
| US-20190128871-A1 | 3d cell culture and ex vivo drug testing methods | Inactive | 15-Nov-2013 | ||
| WO-2015073724-A1 | 3d cell culture and ex vivo drug testing methods | Inactive | 15-Nov-2013 | G01N33/5011 |
Molecular Response Signals
Molecular Response Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Molecular Response FAQs
-
When was Molecular Response founded?
Molecular Response was founded in 2010.
-
Where is Molecular Response headquartered?
Molecular Response is headquartered in San Diego, CA.
-
What is the size of Molecular Response?
Molecular Response has 15 total employees.
-
What industry is Molecular Response in?
Molecular Response’s primary industry is Biotechnology.
-
Is Molecular Response a private or public company?
Molecular Response is a Private company.
-
What is Molecular Response’s current revenue?
The current revenue for Molecular Response is .
-
Who are Molecular Response’s investors?
Biotech Investment Group has invested in Molecular Response.
-
Who are Molecular Response’s competitors?
MatTek, iXCells Biotechnologies, Maze Therapeutics, Cell Biologics, and BioIVT are some of the 21 competitors of Molecular Response.
-
When was Molecular Response acquired?
Molecular Response was acquired on 05-Mar-2018.
-
Who acquired Molecular Response?
Molecular Response was acquired by BioDuro-Sundia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process